Synaptic determinants of cholinergic interneurons hyperactivity during parkinsonism

Area of Science:

• Neuroscience
• Neurodegenerative Diseases
• Cellular Electrophysiology

Background:

• Parkinson's disease involves dopamine loss in the basal ganglia, leading to altered neurotransmitter balance.
• This imbalance disrupts striatal circuitry and neuron activity, particularly in dopamine-depleted states.
• Changes in striatal tonically active interneurons, including cholinergic interneurons (CINs), are implicated in Parkinson's disease pathology.

Purpose of the Study:

• To investigate the contribution of striatal CINs to pathological hyperactivity in dopamine-depleted conditions.
• To determine the role of extrinsic synaptic inputs in driving CIN hyperactivity.
• To explore potential therapeutic targets for Parkinson's disease based on CIN activity.

Main Methods:

• Electrophysiological recordings and calcium imaging in Cre-mice.
• Single-cell resolution analysis of identified CINs in ex vivo brain slices.
• Evaluation of intrinsic neuronal properties and synaptic input effects.

Main Results:

• Dopamine-depleted striatal circuits exhibit pathological hyperactivity.
• CINs display hyperactivity, characterized by bursts and silences, in dopamine-depleted striata.
• Both intrinsic properties and extrinsic glutamatergic, GABAergic, and nicotinic cholinergic inputs contribute to CIN hyperactivity.

Conclusions:

• CINs are the primary drivers of pathological striatal hyperactivity in Parkinson's disease.
• Extrinsic synaptic inputs significantly contribute to CIN hyperactivity and altered firing patterns.
• Targeting CINs and their synaptic inputs presents a promising therapeutic avenue for Parkinson's disease.